We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+3.7%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
AUM
$423M
AUM Growth
+$18M
Cap. Flow
+$6.76M
Cap. Flow %
1.6%
Top 10 Hldgs %
75.32%
Holding
416
New
28
Increased
170
Reduced
43
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 19.97%
2 Consumer Discretionary 4.63%
3 Consumer Staples 4.48%
4 Financials 3.96%
5 Industrials 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAL icon
251
Halliburton
HAL
$27.1B
$7.67K ﹤0.01%
262
+2
+0.8% +$63
HPE icon
252
Hewlett Packard
HPE
$69.4B
$7.55K ﹤0.01%
362
-122
-25% -$2.33K
TRMD icon
253
TORM
TRMD
$3.02B
$7.53K ﹤0.01%
250
INTU icon
254
Intuit
INTU
$88.1B
$7.37K ﹤0.01%
12
FPX icon
255
First Trust US Equity Opportunities ETF
FPX
$1.49B
$7.18K ﹤0.01%
63
PKW icon
256
Invesco BuyBack Achievers ETF
PKW
$1.75B
$6.96K ﹤0.01%
59
SBS icon
257
Sabesp
SBS
$18.9B
$6.94K ﹤0.01%
2,202
STLA icon
258
Stellantis
STLA
$20.9B
$6.88K ﹤0.01%
528
CCL icon
259
Carnival Corporation Ltd
CCL
$39.4B
$6.42K ﹤0.01%
300
CION icon
260
CION Investment
CION
$362M
$6.39K ﹤0.01%
529
+15
+3% +$181
VRTX icon
261
Vertex Pharmaceuticals
VRTX
$123B
$6.33K ﹤0.01%
13
GIS icon
262
General Mills
GIS
$19.3B
$6.3K ﹤0.01%
89
+1
+1% +$69
SRLN icon
263
State Street Blackstone Senior Loan ETF
SRLN
$5.33B
$6.21K ﹤0.01%
148
+4
+3% +$166
VIG icon
264
Vanguard Dividend Appreciation ETF
VIG
$114B
$6.18K ﹤0.01%
31
BMY icon
265
Bristol-Myers Squibb
BMY
$131B
$6.12K ﹤0.01%
115
+2
+2% +$94
SLYG icon
266
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.17B
$6.08K ﹤0.01%
64
PHM icon
267
Pultegroup
PHM
$24.7B
$5.9K ﹤0.01%
40
COF icon
268
Capital One
COF
$135B
$5.64K ﹤0.01%
36
VCIT icon
269
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$5.49K ﹤0.01%
66
-49
-43% -$4.03K
SYK icon
270
Stryker
SYK
$129B
$5.43K ﹤0.01%
15
+10
+200% +$3.45K
D icon
271
Dominion Energy
D
$58.8B
$5.36K ﹤0.01%
89
+1
+1% +$55
ECOR icon
272
electroCore
ECOR
$60.4M
$5.33K ﹤0.01%
666
REGN icon
273
Regeneron Pharmaceuticals
REGN
$79.5B
$5.04K ﹤0.01%
5
HPQ icon
274
HP
HPQ
$25.8B
$4.91K ﹤0.01%
132
+1
+0.8% +$35
SH icon
275
ProShares Short S&P500
SH
$902M
$4.8K ﹤0.01%
112
+1
+0.9% +$45

Similar funds

Kozak & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Kozak & Associates held 416 positions worth $423M, up 4.4% from $405M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Kozak & Associates's Q3 2024 filing shows 28 new, 170 increased, 43 reduced and 24 closed positions. Its largest new stake was Invesco S&P SmallCap Momentum ETF: 39,102 shares worth $2.66M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $928K.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Kozak & Associates's largest Q3 2024 buy was Invesco S&P SmallCap Momentum ETF: 39,102 shares worth $2.66M.
  • Kozak & Associates added most to Lam Research in Q3 2024, an estimated $2.66M increase.
  • Kozak & Associates's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $928K.
  • Kozak & Associates fully exited Johnson Controls International in Q3 2024, selling an estimated $72K.
  • Kozak & Associates's ten largest holdings make up 75% of its $423M portfolio in Q3 2024.
  • Kozak & Associates opened 28 new positions and closed 24 in Q3 2024.
  • Kozak & Associates's portfolio value rose 4.4% quarter-over-quarter to $423M.

Based on Kozak & Associates's 13F filing for Q3 2024, filed 17 Oct 2024.